HLB Therapeutics is committed
to sustainability as a core value,
leading efforts in environmental
management practices such as carbon
reduction and resource recycling.
HLB Therapeutics has adopted sustainability as a core value encompassing both the present and the future,
and is dedicated to ESG management activities. To this end, we are establishing medium- to long-term plans
for environmental management, including carbon reduction and resource recycling.
Moving forward, HLB Therapeutics will continue to respect and support key issues and values related to
the environment, human rights, labor, anti-corruption, and community as outlined in the UN Universal Declaration
of Human Rights, the UN SDGs, the UN Global Compact Ten Principles, UNICEF's CRBP Ten Principles,
and the OECD Guidelines for Multinational Enterprises. We will lead as a global company in these areas.
We are committed to ensuring that ESG is not merely a declarative slogan
but translates into concrete and practical business outcomes.
HLB Therapeutics will strive for the sustainable happiness of all stakeholders and the advancement of global society.
Thank you.
HLB Therapeutics Co., Ltd. CEO Ki-hong Ahn